journal of nanobiotechnology biomed central2 materials and methods the flow chamber system the flow...

9
BioMed Central Page 1 of 9 (page number not for citation purposes) Journal of Nanobiotechnology Open Access Research The margination propensity of spherical particles for vascular targeting in the microcirculation Francesco Gentile 1 , Antonio Curcio 2 , Ciro Indolfi 2 , Mauro Ferrari 3,4 and Paolo Decuzzi* 1,3 Address: 1 Center of Bio-/Nanotechnology and -/Engineering for Medicine University of Magna Graecia at Catanzaro, Viale Europa – Loc. Germaneto, 88100, Catanzaro, Italy, 2 Division of Cardiology, University of Magna Graecia at Catanzaro Viale Europa – Loc. Germaneto, 88100, Catanzaro, Italy, 3 The University of Texas Health Science Center Houston 1825 Pressler St, Houston, Texas, 77030, USA and 4 M.D. Anderson Cancer Center and Rice University 1825 Pressler St, Houston, Texas, 77030, USA Email: Francesco Gentile - [email protected]; Antonio Curcio - [email protected]; Ciro Indolfi - [email protected]; Mauro Ferrari - [email protected]; Paolo Decuzzi* - [email protected] * Corresponding author Abstract The propensity of circulating particles to drift laterally towards the vessel walls (margination) in the microcirculation has been experimentally studied using a parallel plate flow chamber. Fluorescent polystyrene particles, with a relative density to water of just 50 g/cm 3 comparable with that of liposomal or polymeric nanoparticles used in drug delivery and bio-imaging, have been used with a diameter spanning over three order of magnitudes from 50 nm up to 10 μm. The number of particles marginating per unit surface have been measured through confocal fluorescent microscopy for a horizontal chamber, and the corresponding total volume of particles has been calculated. Scaling laws have been derived as a function of the particle diameter d. In horizontal capillaries, margination is mainly due to the gravitational force for particles with d > 200 nm and increases with d 4 ; whereas for smaller particles increases with d 3 . In vertical capillaries, since the particles are heavier than the fluid they would tend to marginate towards the walls in downward flows and towards the center in upward flows, with increasing with d 9/2 . However, the margination in vertical capillaries is predicted to be much smaller than in horizontal capillaries. These results suggest that, for particles circulating in an external field of volume forces (gravitation or magnetic), the strategy of using larger particles designed to marginate and adhere firmly to the vascular walls under flow could be more effective than that of using particles sufficiently small (d < 200 nm) to hopefully cross a discontinuous endothelium. 1 Introduction In the early diagnosis, treatment and imaging of diseases, as cancer and cardiovascular, the use of microparticles and nanoparticles is emerging as a powerful tool [1,2]. These are sufficiently small 'vectors' of therapeutic or/and imag- ing agents to be systemically administered, transported by Published: 15 August 2008 Journal of Nanobiotechnology 2008, 6:9 doi:10.1186/1477-3155-6-9 Received: 5 January 2008 Accepted: 15 August 2008 This article is available from: http://www.jnanobiotechnology.com/content/6/1/9 © 2008 Gentile et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. n s V s V s V s V s brought to you by CORE View metadata, citation and similar papers at core.ac.uk provided by Springer - Publisher Connector

Upload: others

Post on 17-May-2021

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Journal of Nanobiotechnology BioMed Central2 Materials and methods The Flow Chamber System The flow chamber system consists in a parallel plate flow chamber (from Glycotech – Rockville,

BioMed CentralJournal of Nanobiotechnology

ss

brought to you by COREView metadata, citation and similar papers at core.ac.uk

provided by Springer - Publisher Connector

Open AcceResearchThe margination propensity of spherical particles for vascular targeting in the microcirculationFrancesco Gentile1, Antonio Curcio2, Ciro Indolfi2, Mauro Ferrari3,4 and Paolo Decuzzi*1,3

Address: 1Center of Bio-/Nanotechnology and -/Engineering for Medicine University of Magna Graecia at Catanzaro, Viale Europa – Loc. Germaneto, 88100, Catanzaro, Italy, 2Division of Cardiology, University of Magna Graecia at Catanzaro Viale Europa – Loc. Germaneto, 88100, Catanzaro, Italy, 3The University of Texas Health Science Center Houston 1825 Pressler St, Houston, Texas, 77030, USA and 4M.D. Anderson Cancer Center and Rice University 1825 Pressler St, Houston, Texas, 77030, USA

Email: Francesco Gentile - [email protected]; Antonio Curcio - [email protected]; Ciro Indolfi - [email protected]; Mauro Ferrari - [email protected]; Paolo Decuzzi* - [email protected]

* Corresponding author

Abstract

The propensity of circulating particles to drift laterally towards the vessel walls (margination) in themicrocirculation has been experimentally studied using a parallel plate flow chamber. Fluorescentpolystyrene particles, with a relative density to water of just 50 g/cm3comparable with that ofliposomal or polymeric nanoparticles used in drug delivery and bio-imaging, have been used with a

diameter spanning over three order of magnitudes from 50 nm up to 10 μm. The number of

particles marginating per unit surface have been measured through confocal fluorescent

microscopy for a horizontal chamber, and the corresponding total volume of particles has been

calculated. Scaling laws have been derived as a function of the particle diameter d. In horizontalcapillaries, margination is mainly due to the gravitational force for particles with d > 200 nm and

increases with d4; whereas for smaller particles increases with d3. In vertical capillaries, since

the particles are heavier than the fluid they would tend to marginate towards the walls in

downward flows and towards the center in upward flows, with increasing with d9/2. However,

the margination in vertical capillaries is predicted to be much smaller than in horizontal capillaries.These results suggest that, for particles circulating in an external field of volume forces (gravitationor magnetic), the strategy of using larger particles designed to marginate and adhere firmly to thevascular walls under flow could be more effective than that of using particles sufficiently small (d <200 nm) to hopefully cross a discontinuous endothelium.

1 IntroductionIn the early diagnosis, treatment and imaging of diseases,as cancer and cardiovascular, the use of microparticles and

nanoparticles is emerging as a powerful tool [1,2]. Theseare sufficiently small 'vectors' of therapeutic or/and imag-ing agents to be systemically administered, transported by

Published: 15 August 2008

Journal of Nanobiotechnology 2008, 6:9 doi:10.1186/1477-3155-6-9

Received: 5 January 2008Accepted: 15 August 2008

This article is available from: http://www.jnanobiotechnology.com/content/6/1/9

© 2008 Gentile et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

ns

Vs

Vs Vs

Vs

Page 1 of 9(page number not for citation purposes)

Page 2: Journal of Nanobiotechnology BioMed Central2 Materials and methods The Flow Chamber System The flow chamber system consists in a parallel plate flow chamber (from Glycotech – Rockville,

Journal of Nanobiotechnology 2008, 6:9 http://www.jnanobiotechnology.com/content/6/1/9

the blood flow along the circulatory system and eventu-ally recognize the diseased microenvironment (diseasedcells). A nanoparticle comprises an internal core with theactive agents and an external coating whit tailored phys-ico-chemical properties. The interaction of the vectorswith the biological target (diseased cell) is generally gov-erned by specific forces, mediated by the formation anddestruction of molecular bonds [3], and by non-specificinteractions regulated by short ranged forces as van derWaals, electrostatic and steric [4].

Two different delivery strategies are currently under inves-tigation and development: a passive targeting of the diseasedmicroenvironment relying on the permeability of the bloodvessels (enhanced retention and permeability effect), and anactive targeting of the diseased microvasculature relying onthe recognition of specific molecules overexpressed at thesite of interest [5]. It is known that tumor microvesselsexhibit a significant increase in permeability to large mol-ecules with intercellular openings and intercellular gaps aslarge as a micron [6], which could be crossed by suffi-ciently small particles. However the level of permeabilityis strongly dependent on the type of tumor, the site wherethe tumor is developing, the state of the tumor and thetherapeutic treatment, and significant differences can beobserved between human and xenografts tumors [7]. Inaddition to this, diseases other than cancer do no showany significant vessel permeability, thus making a passivetargeting strategy non appropriate. On the other hand, agrowing body of evidences support the idea that specificmolecules are overexpressed at the surface of a diseasedvasculature [8], which could be used as 'docking sites' forcirculating particles. Following a microvas-culature target-ing strategy could possibly be more effective than just rely-ing on the matching between the size of the particles andthat of the vascular fenestrations. Evidently, the specificrecognition and firm adhesion of a circulating particle tothe vessel walls under flow is far from being an easy task.

For both delivery strategies, the systemically administeredparticles should be designed to move in close proximity tothe vascular walls, 'sense' any significant biological differ-ence between normal and abnormal endothelium andseek for fenestrations in the case of a passive strategy, orfor specific vascular receptors, in the case of an active tar-geting strategy. In other words, the nanoparticles shouldbe designed to spontaneously 'marginate', i.e. drift later-ally towards the vessel walls, and interact with the bloodvessels rather than 'navigating' in the center of the capil-lary as red blood cells (RBCs) do or, even worse, adheringand being transported by the RBCs. It is here important torecall that in physiology the term margination is referredto the lateral drifting of leukocytes which have beenobserved experimentally to collect near the walls of bloodvessels. This behavior has been mainly associated to the

interaction of leukocytes with RBCs which tend to pushthe former away from the center of the capillary towardsthe opposing wall [9], and it is no at all related to gravita-tional forces, as clearly demonstrated by [10]. Systemi-cally administered particles for the delivery of drugs andother therapeutic agents have a characteristic size at leastone order of magnitude smaller than leukocytes and RBCs(O (10) μm), and, more importantly, than the thickness ofthe cell free layer (O (10) μm). As a consequence, the mar-gination of nanoparticles can not only rely on the interac-tion with other circulating cells, especially in themicrocirculation where RBCs are less abundant. The mar-gination dynamics of nanoparticles has to be controlledby their size, their shape and their possible interactionwith external long range force fields, as the gravitationaland electromagnetic fields.

In this work, the propensity to marginate of classicalspherical particles in a laminar flow and under the effectof gravitational forces is studied. Particles with differentdiameters spanning from 50 nm up to 10 μm are infusedwithin a parallel plate flow chamber mimicking the phys-iological conditions of human microcirculation. The den-sity of the particles relative to water is of just 50 g/cm3,comparable with that of liposomal and polymeric basedparticles used in such applications.

2 Materials and methodsThe Flow Chamber SystemThe flow chamber system consists in a parallel plate flowchamber (from Glycotech – Rockville, MD) installedupon a 35 mm cell culture dish, where the particles areinjected by means of a Harvard Apparatus syringe pump.The chamber is made up of a PMMA flow deck with aninlet and an outlet holes connected through silastic tubingto a syringe pump and a reservoir respectively (Fig. 1). Sit-ting between the chamber and the dish, a silicon rubbergasket defines the geometry of the channel where the par-ticle solution is introduced. The gasket used in the presentexperiments has a thickness h of 254 μm (0. 01 in), awidth w of 1 cm and a length L of 2 cm. The volumetricflow rate Q defined through the syringe pump has beenfixed equal to 50 μl/min for all the experiments. Based onthese data, the mean velocity U (= Q/(wh)) within thechamber is of about 0. 328 mm/s, a physiologically rele-vant value for human capillaries; the shear rate S at thesubstrate is given by the commonly used relation

S = 6Q/h2w = 7.75 s-1 (1)

and the shear stress at the wall ηS = 7. 75 × 10-3 Pa beingη = 10-3 Pa s the viscosity of water. The channel Reynoldsnumber (= ρUh/η) is equal to about 8 × 10-2. The shearrate and the shear stress are sufficiently small to allow forthe non-specific cell-particle adhesion. Experiments were

Page 2 of 9(page number not for citation purposes)

Page 3: Journal of Nanobiotechnology BioMed Central2 Materials and methods The Flow Chamber System The flow chamber system consists in a parallel plate flow chamber (from Glycotech – Rockville,

Journal of Nanobiotechnology 2008, 6:9 http://www.jnanobiotechnology.com/content/6/1/9

performed at room temperature (24°C) for a maximumtime of 10 min.

The Measurement Set-upThe flow chamber was mounted on the stage of a LeicaTCS-SP2® laser scanning confocal microscope system pro-vided with a DM-IRB inverted microscope. The cells andthe particles in the chamber were imaged using a 20× drymicroscope objective – a field of view comprising 325 ×325 μm2 was mapped into 256 × 256 lines, a resolutionallowing for a line frequency of 800 Hz, and an acquisi-tion rate derived as 800/256 � 3 fps, which is fast enoughto record continuously the dynamics of the particles. Thepinhole (~80 μm) and laser power (argon/krypton: 80%power) were maintained throughout each experiment.Confocal images of green fluorescence were collectedusing a 488 nm excitation light. Both the Bright Fieldimages of the cell substrate and the fluorescent confocal

images of the nanoparticles were exported as tiff files intoMatLAB® and Mathematica® where were deconvolutedusing in-house developed software. The number of parti-cles adhering to the whole substrate within the region ofinterest and the number of particles adherent to the solecells within the region of interest were monitored for thewhole duration of the experiment. Fig. 2 presents the totalnumber of particles adhering within the region of interestfor three different particles sizes.

Cell CultureHuman umbilical vein endothelial cells (HUVECs) werepurchased from Cambrex, Inc. (East Rutherford, NJ). Cellswere maintained in EGMTM-2 – Endothelial CellMedium-2 (Cambrex Bio Science Walkersville Inc., MD)supplemented with 2% FBS, 0. 04% hydrocortisone, 0.4% hFGF-B, 0. 1% VEGF, 0. 1% rIGF-1, 0. 1% ascorbicacid, 0. 1% hEGF, 0. 1% GA-1000, 0. 1% heparin, 100 U/

The PMMA flow deck of the flow chamber with the inlet and outlet tubings, and the gasket with a thickness of 254 μmFigure 1The PMMA flow deck of the flow chamber with the inlet and outlet tubings, and the gasket with a thickness of 254 μm.

Page 3 of 9(page number not for citation purposes)

Page 4: Journal of Nanobiotechnology BioMed Central2 Materials and methods The Flow Chamber System The flow chamber system consists in a parallel plate flow chamber (from Glycotech – Rockville,

Journal of Nanobiotechnology 2008, 6:9 http://www.jnanobiotechnology.com/content/6/1/9

mL penicillin, and 100 μg/mL streptomycin and weregrown at 37°C with humidified 95% air/5% CO2.

For each experiment, cells were plated on a borosilicateglass with a 0. 2 mg/cm2 substratum of type A gelatine(Sigma-Aldrich Corporation, MO). When HUVECsreached 80% confluence, the borosilicate glass wasdetached from the bottom of the plate and mounted inthe parallel plate flow chamber for particle-cell adhesionanalysis.

The ParticlesFluoresbrite® Microspheres from Polysciences were used.These are Yellow Green fluorescent particles with an exci-tation maximum at 441 nm and an emission maximum at486 nm. Particles with different sizes were used namely 50nm, 100 nm, 200 nm, 500 nm, 750 nm, and 1 μm, 6 μm, 10μm.

3 Results and discussionsThe lateral drifting of particulates in capillary flow hasbeen analyzed since the pioneering experiments of Pois-uille in 1836 [11] who observed that RBCs do not distrib-

ute uniformly leaving a region devoid of particles in closeproximity to the walls: the cell free layer. More recently,Segré and Silberberg [12] have showed that for small Rey-nolds numbers a bolus of neutrally-buoyant particleswould preferentially migrate towards the walls of the tubeleading to a non uniform radial distribution with a peakat about 0. 6 times the capillary radius. After Segré, manyauthors experimentally investigated the behavior of nonneutrally buoyant rigid spheres [13-16], finding out thatthe equilibrium position would depend on the relativedensity of the particles to the fluid and the flow Reynoldsnumber. In 1994, Hogg [17] has presented a comprehen-sive theoretical analysis for the migration of non-neutrallybuoyant spherical particles in two-dimensional shearflows. Three different dimensionless parameters havebeen introduced to describe the problem: the geometricratio α (= d/(2h)) between the particle diameter d and thechannel height h; the channel Reynolds number Rec (=ρfUmRh/μ) with ρf the density, μ the viscosity and Um themean flow velocity of the fluid, and the hydraulic radiusRh of the channel (Rh = 2hw/(h + w)); and the buoyancynumber B = d2 Δρg/(18 μUm), being Δρ the density of theparticle relative to the fluid. Different marginating behav-

The number n × 103 of marginating particles as a function of time during a typical flow chamber experiment for three different particle sizes (d = 50 nm; 750 nm and 10 μm)Figure 2The number n × 103 of marginating particles as a function of time during a typical flow chamber experiment for three different particle sizes (d = 50 nm; 750 nm and 10 μm).

Page 4 of 9(page number not for citation purposes)

Page 5: Journal of Nanobiotechnology BioMed Central2 Materials and methods The Flow Chamber System The flow chamber system consists in a parallel plate flow chamber (from Glycotech – Rockville,

Journal of Nanobiotechnology 2008, 6:9 http://www.jnanobiotechnology.com/content/6/1/9

iors have been identified depending on the values of thecombined parameters α2/B and RecB2 compared to unity.In the microcirculation, with Um of O (100) μm/s, h and Rhof O (100) μm, and for d of O (10) μm and smaller, it fol-lows

having considered μ = 10-3 Pa s, Δρ = 50 kg/m3 and ρf = 103

kg/m3. For the flow chamber apparatus considered hereand d = 10 μm, it is α � 0. 04, Rec � 0. 16 and B � 0. 053leading to α2/B � 0. 03 and RecB2 � 4. 6 × 104, muchsmaller than unity.

3.1 Margination in Horizontal CapillariesFor α2/B < 1 and RecB2 < 1, as observed in [17], the lateraldrift is mainly due to the gravitational force acting orthog-onally to the flow direction and the drifting velocity isonly slightly different from that predicted by Stokes forthe settling of a particle in a quiescent fluid, that is to say

where �h� is the average separation distance of the particlefrom the wall (see Fig. 3). Integrating (2) over an initialseparation distance �Ho�, and observing that when at �Ho�the particle would move longitudinally by the distance Lin a time Δt = L/(S�Ho�), it follows that

where L is the length of the region of interest with surfacearea A. Notice that in the case of a magnetic particle driventowards the chamber substrate by an external magneticfield, �Ho� would scale with d as in (3), being the magneticforce Fmag proportional to the volume of the particle, justas the gravitation force. The separation distance �Ho� mul-tiplied by A gives the volume of fluid within which arecomprised the particles candidate to sediment within theregion of interest (the sedimentation volume). If C is thelocal concentration of the particles within the sedimenta-tion volume, the number of depositing particles per unitarea A is readily given by

whereas the total volume of settling particles per unit

surface is defined as

Substituting in (4) and (5) for (3), it follows that under a

gravitational field (or magnetic field) the number of

a mr

r r

m2

22 2 2

219

210

118

10/ ( ) ( )BU

h gO Re B R d

gOm

c hf= < = <− −

ΔΔ

and

vd hdt

gd BUG

m= ⟨ ⟩ = =118

2Δrm

(2)

⟨ ⟩ =⎡

⎣⎢

⎦⎥ ×H

g LS

do2 21

18Δrm

(3)

nCV

AC H C ds

so= = ⟨ ⟩ ∝ × (4)

Vs

V C H d C ds o= ⟨ ⟩ × ∝ ×p 3 46/ (5)

ns

The margination trajectory of a spherical particle within a laminar flowFigure 3The margination trajectory of a spherical particle within a laminar flow.

Page 5 of 9(page number not for citation purposes)

Page 6: Journal of Nanobiotechnology BioMed Central2 Materials and methods The Flow Chamber System The flow chamber system consists in a parallel plate flow chamber (from Glycotech – Rockville,

Journal of Nanobiotechnology 2008, 6:9 http://www.jnanobiotechnology.com/content/6/1/9

settling particles per unit area and their volume are

both proportional to the local volume concentration C of

particles and grows linearly with d ( ∝ d) and with the

fourth power of d ( ∝ d4), respectively.

The above 'back of the envelope' calculations, althoughextremely simplified, are in decent agreement with theexperimental results obtained using the parallel plate flowchamber apparatus. The total volume of the particles set-

tling per unit surface is shown as a function of the par-

ticle diameter in Fig. 4, ranging between 500 nm and 10

μm. These experiments have been performed keepingfixed the total volume of the particles injected into the

chamber (i.e. 5. 2 × 107 μm3/ml) for each particle size, orin other words, the total number of particles injecteddecreases with d-3. In a double-logarithm diagram, the

average values of over five significant repetitions

(filled boxes) are well aligned around a straight line witha nearly unit slope described by the relation

which gives almost the same scaling as predicted in (5),assuming a fixed total volume of injected particles. In Fig.

5, the variation of the volume as a function of the total

number of particles injected ntot in the flow chamber is plot-

ted for a fixed particle size (d = 500 nm), showing a linear

increase of following the experimental relationship

which support the linear relationship between and C

as predicted in (5).

Vs

ns

Vs

Vs

Vs

V d Rs = =1454 6 0 9761 2 2. , .. with (6)

Vs

Vs

V n Rs tot= × =−196 10 0 9816 0 956 2. , .with (7)

Vs

The volume of particles marginating per unit surface as a function of the particle diameter d ranging from 500 nm up to 10 μm (fixed total volume of the injected particles Vtot = 5.2 × 107 μm 3 and Cv = 5.2 × 105)Figure 4

The volume of particles marginating per unit surface as a function of the particle diameter d ranging from 500 nm up to 10

μm (fixed total volume of the injected particles Vtot = 5.2 × 107 μm 3 and Cv = 5.2 × 105).

0.5 0.6 0.7 1.1. 1.5 2. 3. 4. 5. 6. 7. 10.10.d �Μm�

2

5

lO3

2

5

lO4

2

5

V �Μm3�mm2� Fixed Total Volume

1454.6d1.25488

Vs

Page 6 of 9(page number not for citation purposes)

Page 7: Journal of Nanobiotechnology BioMed Central2 Materials and methods The Flow Chamber System The flow chamber system consists in a parallel plate flow chamber (from Glycotech – Rockville,

Journal of Nanobiotechnology 2008, 6:9 http://www.jnanobiotechnology.com/content/6/1/9

In Fig. 6, the behavior of the smaller particles is consid-ered with a diameter ranging from 200 nm down to 50 nm.However, differently from the previous case, shown in Fig.4, the analysis has been performed for a fixed number ofinjected particles (ntot = 108), to limit the total amount of

particles to be used for a diameter of 50 nm. The - d

relation is different from that observed for the larger par-ticles, and it is no more nearly linear in a double-loga-rithm diagram being

whose scaling with d can not be predicted by just gravita-tion or volume forces. For these small particles otherforces as colloidal forces (van der Waals, electrostatic) areprobably responsible for their margination, which ariseonly with a small separation distance between the particleand the substrate (tens to a hundred nanometers). AnANOVA analysis has returned, for the data presented in

Fig. 4 to 6, p values much smaller than the critical value of0. 05, being respectively p = 0. 0022, p = 0. 0035, and p =0. 0047, thus implying a statistically significant differenceamong the means.

3.2 Margination in Vertical Capillaries

For α2/B and RecB2 smaller than unity, as observed in [17],

in vertical capillaries the lateral drift is modest with a

velocity scaling with , where Rp is the particle Rey-

nolds number (Rp = ρpUmd2/(μRch)). Therefore the lateral

drifting velocity would scale with d3rather with d2 as inhorizontal capillaries (see eq.2), making the characteristicsize of the particles even more important. Following thesame reasonings as above for the horizontal capillaries, it

can be derived a �Ho� scaling with d3/2, and eventually a

number and a volume of settling particles per unit

area proportional to the local volume concentration C of

Vs

V d Rs = =314 5 0 9983 2 2. , .. with (8)

BRp1 2/

ns Vs

The volume of particles marginating per unit surface as a function of the particle total number ntot (fixed diameter d = 500 nm)Figure 5

The volume of particles marginating per unit surface as a function of the particle total number ntot (fixed diameter d = 500 nm).

107 108 8 108ntot

103

102

10

103

V �Μm3�mm2�

1.96075�10�6 n0.95648

Vs

Page 7 of 9(page number not for citation purposes)

Page 8: Journal of Nanobiotechnology BioMed Central2 Materials and methods The Flow Chamber System The flow chamber system consists in a parallel plate flow chamber (from Glycotech – Rockville,

Journal of Nanobiotechnology 2008, 6:9 http://www.jnanobiotechnology.com/content/6/1/9

particles and scaling respectively with d3/2 and d9/2 ( ∝

d3/2 and ∝ d9/2).

The lateral drifting observed in vertical capillaries is againassociated with the difference in relative density betweenthe circulating particle and the fluid, being B, the buoy-ancy parameter, different from zero. But more impor-tantly, the sign of the velocity depends on the direction ofthe flow: particles heavier than the fluid would drifttowards the wall for downward flows (margination) andtowards the capillary center line for upward flows (oppo-site of margination). The opposite has been predicted andobserved to occur for particles less heavy than the fluid.These behavior has been observed extensively in severalexperiments [18].

4 ConclusionThe propensity of spherical nanoparticles to marginatetowards the vessel walls in the microcirculation has beenanalyzed employing a parallel plate flow chamber. Theeffect of the particle size and orientation of the capillarywith respect to external volume force fields (gravitation)

has been elucidated experimentally and supported bysimple scaling relations.

The number and total volume of particles margin-

ating per unit surface have been measured through confo-cal fluorescent microscopy. Considering particles with adensity slightly larger than water (1050 kg/m3), and com-parable with the density of liposomes and polymeric par-ticles used in nanomedical applications, it has beenobserved in horizontal channels that the lateral margina-tion of particles with a diameter larger than 200 nm is

mainly governed by the gravitational force with and

scaling both proportionally to the volume concentra-

tion C of the particles and, respectively, to the diameter dand the fourth power of the diameter d4. For smaller par-ticles (d < 200 nm), the margination dynamics can not be

associated to gravitational forces being ∝ d3.2. Possi-

bly, in this case, colloidal interactions may govern particlelateral drifting but this would already require the particle

ns

Vs

ns Vs

ns

Vs

Vs

The volume of particles marginating per unit surface as a function of the particle diameter d ranging from 50 to 200 nm (fixed total number of the injected particles ntot = 108 and C = 1014 m-3)Figure 6

The volume of particles marginating per unit surface as a function of the particle diameter d ranging from 50 to 200 nm

(fixed total number of the injected particles ntot = 108 and C = 1014 m-3).

5 6 7 8 9 lO�1 1.5 2d �Μm�

lO�2

2

5

0.1

0.2

0.5

1.1.

2.

V �Μm3�mm2� Fixed Total Number

314.47 d3.20

Vs

Page 8 of 9(page number not for citation purposes)

Page 9: Journal of Nanobiotechnology BioMed Central2 Materials and methods The Flow Chamber System The flow chamber system consists in a parallel plate flow chamber (from Glycotech – Rockville,

Journal of Nanobiotechnology 2008, 6:9 http://www.jnanobiotechnology.com/content/6/1/9

Publish with BioMed Central and every scientist can read your work free of charge

"BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime."

Sir Paul Nurse, Cancer Research UK

Your research papers will be:

available free of charge to the entire biomedical community

peer reviewed and published immediately upon acceptance

cited in PubMed and archived on PubMed Central

yours — you keep the copyright

Submit your manuscript here:http://www.biomedcentral.com/info/publishing_adv.asp

BioMedcentral

to be in sufficient close proximity of the wall, say tens upto a hundred nanometer, in other words separation dis-tances of the same order of magnitude of the particle size.

These results, although not exhaustive, are of interest inthe systemic delivery of nanoparticles designed to targetthe vascular walls in the microcirculation. The experimen-tal results and simple theoretical relations support theidea of using large particles rather than small particleswith the same total volume. In fact, if the biological targetis the vascular wall and the particles are not required tofreely extravasate through the discontinuous endothe-lium, then the larger spherical particles would more easilysediment in horizontal capillaries and drift laterally invertical capillaries with downward flow. Also the largerspherical particles would have a larger surface exposed tothe vascular cells increasing the likelihood of firm adhe-sion once decorated with recognizing moieties [3]. Theseparation between large and small particles woulddepend on the relative density compared to the fluid,however for the commonly used liposome and polymericparticles sizes larger than 200 nm would perform better.

It should be noticed, in conclusion, that the presentresults strictly apply when the interaction of the nanopar-ticles with circulating blood cells can be disregarded,which occurs in small capillaries and in the cell free layerof arterioles and veins.

References1. LaVan DA, McGuire T, Langer R: Small-scale systems for in vivo

drug delivery. Nat Biotechnol 2003, 21:1184-91.2. Ferrari M: Cancer nanotechnology: opportunities and chal-

lenges. Nat Rev Cancer 2005, 5:161-71.3. Decuzzi P, Ferrari M: The adhesive strength of non-spherical

particles mediated by specific interactions. Biomaterials 2006,27(30):5307-14.

4. Decuzzi P, Lee S, Bhushan B, Ferrari M: A theoretical model forthe margination of particles within blood vessels. Ann BiomedEng 2005, 33:179-90.

5. Sakamoto J, Annapragada A, Decuzzi P, Ferrari M: Antibiologicalbarrier nanovector technology for cancer applications.Expert Opin Drug Deliv 2007, 4(4):359-69.

6. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, RobergeS, Jain RK, McDonald DM: Openings between defectiveendothelial cells explain tumor vessel leakiness. Am J Pathol2000, 156:1363-80.

7. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP,Jain RK: Regulation of transport pathways in tumor vessels:role of tumor type and microenvironment. Proc Natl Acad SciUSA 1998, 14(95):4607-12.

8. Neri D, Bicknell R: Tumor Vascular Targeting. Nature CancerReviews 2005.

9. Goldsmith HL, Spain S: Margination of leukocytes in blood flowthrough small tubes. Microvasc Res 1984, 27:204-222.

10. Lawrence MB, Kansas GS, Kunkel EJ, Ley K: Threshold levels offluid shear promote leukocyte adhesion through selectins(CD62L,P,E). J Cell Biol 1997, 136(3):717-27.

11. Poiseuille JLM: "Recherches sur les Causes du Mouvement duSang Dans les. Vaisseaux Capillaires". Ann Sci Nat Ser 1836,2(5):111-115.

12. Segré G, Silberberg A: Behavior of macroscopic rigid spheres inPoiseuille flow: Part I. J Fluid Mech 1962, 14:115.

13. Matas J-P, Morris JF, Guazzelli E: Inertial migration of rigid spher-ical particles in Poiseuille flow. J Fluid Mech 2004, 515:171-195.

14. Oliver DR: "Influence of Particle Rotation on Radial Migrationin the Poiseuflle. Flow of Suspensions". Nature 1962,194:1269-1271.

15. Repetti RV, Leonard EF: Segre-Silberberg. annulus formation: apossible explanation. Nature 1964, 203:1346-1350.

16. Jeffrey RC, Pearson JRA: Particle motion in laminar. verticaltube flow. J Fluid Mech 1965, 22:721-735.

17. Hogg AJ: Inertial migration of a non-neutrally buoyant parti-cle in a two-dimensional shear flow. J Fluid Mech 1994,272:285-318.

18. Jeffrey RC, Pearson JRA: Particle motion in laminar verticaltube flow. Journal of Fluid Mechanics 1965, 22:721-735.

Page 9 of 9(page number not for citation purposes)